| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Propafenone hydrochloride |
| Active Ingredient | Propafenone hydrochloride |
| US Brand Names | PROPAFENONE HYDROCHLORIDE (historically RYTHMOL, RYTHMOL SR) |
| Drug Category | Class IC Antiarrhythmic Agent (with mild beta-blocking properties) |
| Route of Administration | Oral |
| FDA Approval Status | FDA approved (October 2002) Approved |
Propafenone Hydrochloride Overview
Propafenone hydrochloride (historically recognized by the brand names Rythmol and Rythmol SR) is an oral prescription medication utilized primarily within Cardiology and Cardiac Electrophysiology. As a Class IC antiarrhythmic agent, it serves as an important medical therapy for managing complex atrial and ventricular heart rhythm disorders.
It is indicated for the prevention of recurrent paroxysmal atrial fibrillation/flutter (AFib/AFL) and paroxysmal supraventricular tachycardias (PSVT) in patients without structural heart disease. It is also indicated for the treatment of documented, life-threatening ventricular arrhythmias (such as sustained ventricular tachycardia).
What Is Propafenone Hydrochloride and How Does It Work?
Propafenone is a Class IC antiarrhythmic drug that stabilizes cardiac membranes by altering electrical signal conduction in heart muscle cells.
It controls abnormal heart rhythms through several mechanisms:
- Potent Sodium Channel Blockade: It strongly inhibits fast sodium channels (Phase 0 of the cardiac action potential), markedly slowing electrical conduction velocity throughout the atria, ventricles, and Purkinje tissue.
- Mild Beta-Adrenergic Blockade: Propafenone possesses weak beta-blocking activity (similar to low-dose propranolol), which helps slow the heart rate and reduce stress-induced rhythm disturbances.
- Refractory Period Extension: It causes a mild prolongation of the effective refractory period in cardiac muscle tissue, preventing rapid, chaotic electrical signals from triggering irregular heartbeats.
Is Propafenone Hydrochloride FDA Approved?
Yes. Propafenone hydrochloride is a fully evaluated and FDA-approved oral medication.
What Is It Used For?
Federal health regulators have authorized this medication for the following specific indications:
- Paroxysmal Atrial Fibrillation/Flutter and PSVT: Indicated to prolong the time to recurrence of symptomatic paroxysmal atrial fibrillation/flutter (AFib/AFL) and paroxysmal supraventricular tachycardia (PSVT) in patients without structural heart disease.
- Life-Threatening Ventricular Arrhythmias: Indicated for the suppression of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgment of the physician are life-threatening.
(Note: “Pill-in-the-pocket” approach is an established off-label clinical strategy using a single oral dose of immediate-release propafenone to terminate acute AFib episodes in select outpatient populations).
Before Taking Propafenone Hydrochloride: Contraindications & Precautions
CAST Black Box Warning: In patients with structural heart disease (such as a previous heart attack / myocardial infarction or heart failure), Class IC antiarrhythmics like propafenone have been shown to increase the risk of mortality and non-fatal cardiac arrest. Therefore, propafenone is strictly restricted to patients WITHOUT significant structural heart disease.
Who Should Not Take This Medication?
- Patients with structural heart disease (e.g., prior myocardial infarction, coronary artery disease, left ventricular hypertrophy, or heart failure).
- Patients with uncontrolled congestive heart failure or cardiogenic shock.
- Patients with severe bradycardia (excessively slow heart rate), sick sinus syndrome, or severe AV block (without an operational pacemaker).
- Patients with severe bronchospastic disorders (like severe asthma) due to its mild beta-blocking properties.
- Patients with severe electrolyte imbalances (like uncorrected hypokalemia or hypomagnesemia).
- Patients with known hypersensitivity to propafenone.
Pregnancy & Breastfeeding
Propafenone is historically classified as a Pregnancy Category C drug. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Propafenone is excreted in human breast milk; caution should be exercised when administered to a nursing woman.
Tell Your Doctor Before Taking It
Inform your cardiologist if you have a history of liver dysfunction, kidney disease, heart failure, asthma, or a pacemaker. Disclose all current medications, especially blood thinners, digoxn, beta-blockers, and antidepressants.
Propafenone Hydrochloride Dosage & Administration
Propafenone comes in two oral formulations: immediate-release (IR) tablets and extended-release (ER) capsules. They are not interchangeable on a mg-for-mg basis.
Standard Dosing
- Immediate-Release Tablets (for AFib/Ventricular Arrhythmias): Treatment is usually initiated at 150 mg taken every 8 hours (450 mg/day). Dosage may be increased at 3- to 4-day intervals to 225 mg every 8 hours, up to a maximum of 300 mg every 8 hours (900 mg/day).
- Extended-Release Capsules (for AFib/PSVT): Treatment is initiated at 225 mg taken every 12 hours. Dosage may be titrated at 5-day intervals up to 325 mg every 12 hours or a maximum of 425 mg every 12 hours.
How It Is Administered
- Take orally with water.
- Extended-release capsules must be swallowed whole. Do not crush, chew, or open the capsules.
- It is generally recommended to take propafenone with food, as food can increase its bioavailability and maintain steady blood levels.
Propafenone Hydrochloride Clinical Efficacy
In patients with structurally normal hearts, propafenone is highly effective at terminating paroxysmal atrial fibrillation and maintaining normal sinus rhythm over long periods. Its dual mechanism of action, potent sodium channel blockade combined with mild beta-blockade, provides effective suppression of both atrial and ventricular arrhythmias while helping prevent rapid heart rate responses during breakthrough episodes.
Propafenone Hydrochloride Side Effects & Safety Profile
Propafenone carries a critical FDA Black Box Warning based on the Cardiac Arrhythmia Suppression Trial (CAST).
Side effects range from mild neurological and gustatory complaints to severe cardiac complications.
Common Side Effects
- Metallic or Bitter Taste (Dysgeusia): A unique, common side effect reported by many patients taking propafenone.
- Dizziness and lightheadedness.
- Nausea, vomiting, or constipation.
- Headache and fatigue.
- Blurred vision.
Serious Adverse Events
- Proarrhythmia: Propafenone can cause new or worsening irregular heartbeats, including transformation of atrial fibrillation into atrial flutter with 1:1 AV conduction (producing dangerously fast heart rates).
- Precipitation of Heart Failure: Due to its mild negative inotropic (weakened contraction) and beta-blocking effects.
- Conduction Disturbances: Can trigger severe heart block or profound bradycardia.
- Agranulocytosis: Extremely rare, severe drop in white blood cells.
Managing Side Effects
If you notice a metallic taste, drinking water or chewing sugar-free gum may help, but discuss it with your doctor if it becomes bothersome. If you experience severe dizziness, chest pain, a sudden racing heart, or swelling in your legs, seek immediate emergency medical care.
Propafenone Hydrochloride Drug Interactions & What to Avoid
Key Interactions
Propafenone is heavily metabolized by the liver enzymes CYP2D6 and CYP3A4, and it acts as an inhibitor of P-glycoprotein (P-gp).
- Digoxin: Propafenone can increase blood levels of digoxin by up to 80-100%, requiring a reduction in digoxin dosage.
- Warfarin: Propafenone increases blood levels of warfarin, prolonging prothrombin time/INR and increasing bleeding risk.
- Beta-Blockers (e.g., Metoprolol, Propranolol): Propafenone significantly increases plasma concentrations of beta-blockers, leading to severe bradycardia and low blood pressure.
- CYP2D6 & CYP3A4 Inhibitors (e.g., Fluoxetine, Paroxetine, Ketoconazole, Erythromycin): These increase propafenone levels in the blood, increasing the risk of fatal proarrhythmia and toxicity.
Food & Alcohol
Avoid grapefruit and grapefruit juice. Grapefruit inhibits CYP3A4, which can cause propafenone blood levels to spike dangerously high. Avoid excessive alcohol consumption, which can independently trigger atrial fibrillation (“holiday heart syndrome”) and worsen dizziness.
Propafenone Hydrochloride Missed Dose, Overdose & Storage
Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time to make up for a missed one.
Overdose
Overdose results in severe cardiac conduction delays, hypotension, severe bradycardia, malignant ventricular arrhythmias, and seizures. Emergency medical treatment is required immediately. Supportive care includes IV inotropes, vasopressors, and cardiac pacing.
Storage Instructions
Store at controlled room temperature between 20°C and 25°C (68°F to 77°F). Keep the container tightly closed and protect it from light and moisture. Keep out of reach of children.
Propafenone Hydrochloride Patient Management & Guidelines
Tests Before & During Treatment
- Baseline Electrocardiogram (ECG): Required to evaluate baseline PR, QRS, and QTc intervals, and to rule out underlying heart block.
- Echocardiogram or Stress Testing: Essential prior to initiation to confirm the absence of structural heart disease (e.g., no prior heart attack or heart failure).
- Electrolyte Panels: Serum potassium and magnesium must be monitored and normalized before and during therapy.
- Liver and Renal Function Tests: Periodic monitoring recommended to ensure proper drug metabolism and clearance.
Do’s and Don’ts
- DO take your medication consistently, preferably with food.
- DO report any sudden fainting, dizziness, or new palpitations to your electrophysiologist immediately.
- DON’T swallow broken, chewed, or crushed extended-release capsules.
- DON’T drink grapefruit juice.
- DON’T stop taking propafenone abruptly without medical guidance.
Frequently Asked Questions
What is propafenone hydrochloride used for?
It is a prescription antiarrhythmic drug used to prevent recurring episodes of abnormal heart rhythms, such as atrial fibrillation (AFib) or paroxysmal supraventricular tachycardia (PSVT), in patients with otherwise healthy hearts.
Why is structural heart disease a contraindication for this drug?
Clinical trials (like the CAST trial) proved that Class IC antiarrhythmics increase the risk of cardiac arrest and death in people who have had a heart attack or have heart failure. Therefore, it is strictly prescribed only to patients with a structurally normal heart.
Why does food or water taste like metal while taking this?
A unique and fairly common side effect of propafenone is a metallic or bitter taste (dysgeusia). This occurs due to the interaction of the drug with taste receptors on the tongue and usually resolves if the medication is stopped.
Can I take my extended-release pill by opening the capsule?
No. Extended-release capsules (Rythmol SR generics) must be swallowed whole. Opening, chewing, or crushing the capsule will release all the medication at once, which can cause a dangerous drug overdose.
Can I eat grapefruit while taking propafenone?
No. Grapefruit and grapefruit juice block the enzymes in your liver that clear propafenone from your body. This can cause the drug to build up to toxic levels, increasing your risk of severe heart complications.
What is the “pill-in-the-pocket” approach?
For select patients with infrequent, sudden episodes of AFib who have healthy hearts, doctors sometimes prescribe a single high dose of immediate-release propafenone to carry with them (“in their pocket”) to take immediately when an episode begins to quickly restore normal sinus rhythm. This should only be done under strict doctor guidance.
References
U.S. Food and Drug Administration (FDA) – Rythmol / Propafenone Hydrochloride prescribing information.
Drugs@FDA Overview – Propafenone Hydrochloride.
American College of Cardiology (ACC) / American Heart Association (AHA) / Heart Rhythm Society (HRS) – Guidelines for the Management of Patients With Atrial Fibrillation.
Legal Disclaimer
The information provided is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding medical conditions or treatment plans.
